Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib

  • Authors:
    • Maria Graziella Catalano
    • Mariateresa Pugliese
    • Roberta Poli
    • Ornella Bosco
    • Raffaello Bertieri
    • Nicoletta Fortunati
    • Giuseppe Boccuzzi
  • View Affiliations

  • Published online on: February 1, 2009     https://doi.org/10.3892/or_00000252
  • Pages: 515-521
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

New therapeutic approaches are mandatory for anaplastic thyroid cancer. We investigated the ability of a new combined treatment using valproic acid (VPA), the only clinically available histone deacetylase inhibitor, and the tyrosine-kinase inhibitor imatinib mesylate to control the cell growth of anaplastic thyroid cancer cell lines. We showed that treatment with imatinib alone is unable to affect the cell growth of anaplastic thyroid cancer cells, whereas in ARO cells, the combined treatment resulted in a cytostatic effect, with clinically achievable doses of imatinib and VPA. The effect is mediated by G1 growth arrest, acting through p21 expression and the impairment of AKT phosphorylation.

Related Articles

Journal Cover

February 2009
Volume 21 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Catalano MG, Pugliese M, Poli R, Bosco O, Bertieri R, Fortunati N and Boccuzzi G: Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib. Oncol Rep 21: 515-521, 2009
APA
Catalano, M.G., Pugliese, M., Poli, R., Bosco, O., Bertieri, R., Fortunati, N., & Boccuzzi, G. (2009). Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib. Oncology Reports, 21, 515-521. https://doi.org/10.3892/or_00000252
MLA
Catalano, M. G., Pugliese, M., Poli, R., Bosco, O., Bertieri, R., Fortunati, N., Boccuzzi, G."Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib". Oncology Reports 21.2 (2009): 515-521.
Chicago
Catalano, M. G., Pugliese, M., Poli, R., Bosco, O., Bertieri, R., Fortunati, N., Boccuzzi, G."Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib". Oncology Reports 21, no. 2 (2009): 515-521. https://doi.org/10.3892/or_00000252